Cover Image
市場調查報告書

Eagle Pharmaceuticals Inc.的產品平台分析

Eagle Pharmaceuticals Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 321354
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Eagle Pharmaceuticals Inc.的產品平台分析 Eagle Pharmaceuticals Inc. - Product Pipeline Review - 2014
出版日期: 2014年12月15日 內容資訊: 英文 26 Pages
簡介

Eagle Pharmaceuticals Inc.是動物用醫藥品的製造企業。進行著抗菌藥、疫苗、驅蟲劑、殺蟲劑等家畜用治療藥及醫藥品的製造開發及銷售。

本報告提供Eagle Pharmaceuticals Inc. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Eagle Pharmaceuticals Inc. 的基本資料

  • Eagle Pharmaceuticals Inc. 概要
  • 主要資訊
  • 企業資料

Eagle Pharmaceuticals Inc. :R&D概要

  • 主要的治療範圍

Eagle Pharmaceuticals Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Eagle Pharmaceuticals Inc. :開發中產品概況

  • 後期階段產品開發中產品
    • 申請登記前的產品/聯合治療模式
  • 在臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段有的開發中產品
    • 前臨床階段的產品/聯合治療模式

Eagle Pharmaceuticals Inc. :藥物簡介

  • bendamustine hydrochloride RTD
  • bendamustine hydrochloride SI
  • EP-4104
  • bivalirudin
  • pemetrexed disodium

Eagle Pharmaceuticals Inc. :開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Eagle Pharmaceuticals Inc. :最新的開發平台資訊

Eagle Pharmaceuticals Inc. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06692CDB

Summary

Global Markets Direct's, 'Eagle Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Eagle Pharmaceuticals Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Eagle Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Eagle Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Eagle Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Eagle Pharmaceuticals Inc.'s pipeline products

Reasons to buy

  • Evaluate Eagle Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Eagle Pharmaceuticals Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Eagle Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Eagle Pharmaceuticals Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Eagle Pharmaceuticals Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Eagle Pharmaceuticals Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Eagle Pharmaceuticals Inc. Snapshot
    • Eagle Pharmaceuticals Inc. Overview
    • Key Information
    • Key Facts
  • Eagle Pharmaceuticals Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Eagle Pharmaceuticals Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Eagle Pharmaceuticals Inc. - Pipeline Products Glance
    • Eagle Pharmaceuticals Inc. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
    • Eagle Pharmaceuticals Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Eagle Pharmaceuticals Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Eagle Pharmaceuticals Inc. - Drug Profiles
    • bendamustine hydrochloride RTD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • bendamustine hydrochloride SI
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EP-4104
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • bivalirudin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pemetrexed disodium
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Eagle Pharmaceuticals Inc. - Pipeline Analysis
    • Eagle Pharmaceuticals Inc. - Pipeline Products by Target
    • Eagle Pharmaceuticals Inc. - Pipeline Products by Route of Administration
    • Eagle Pharmaceuticals Inc. - Pipeline Products by Molecule Type
    • Eagle Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action
  • Eagle Pharmaceuticals Inc. - Recent Pipeline Updates
  • Eagle Pharmaceuticals Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Eagle Pharmaceuticals Inc., Key Information
  • Eagle Pharmaceuticals Inc., Key Facts
  • Eagle Pharmaceuticals Inc. - Pipeline by Indication, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014
  • Eagle Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014
  • Eagle Pharmaceuticals Inc. - Partnered Products in Pipeline, 2014
  • Eagle Pharmaceuticals Inc. - Partnered Products/ Combination Treatment Modalities, 2014
  • Eagle Pharmaceuticals Inc. - Pre-Registration, 2014
  • Eagle Pharmaceuticals Inc. - Phase I, 2014
  • Eagle Pharmaceuticals Inc. - Preclinical, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Target, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014
  • Eagle Pharmaceuticals Inc. - Recent Pipeline Updates, 2014

List of Figures

  • Eagle Pharmaceuticals Inc. - Pipeline by Top 10 Indication, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014
  • Eagle Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Top 10 Target, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Top 10 Route of Administration, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline by Top 10 Molecule Type, 2014
  • Eagle Pharmaceuticals Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top